We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$52.5B
AUM Growth
+$3.43B
Cap. Flow
-$722M
Cap. Flow %
-1.38%
Top 10 Hldgs %
14.5%
Holding
3,132
New
75
Increased
2,208
Reduced
412
Closed
54

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$69.9M
2
TMO icon
Thermo Fisher Scientific
TMO
+$67.9M
3
WFC icon
Wells Fargo
WFC
+$64.1M
4
JPM icon
JPMorgan Chase
JPM
+$63.1M
5
PFE icon
Pfizer
PFE
+$62.5M

Sector Composition

Rank Sector Weight
1 Financials 14.51%
2 Healthcare 13.47%
3 Technology 13.05%
4 Industrials 11.46%
5 Energy 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OESX icon
3051
Orion Energy Systems
OESX
$75.6M
$107K ﹤0.01%
+1,564
New +$82.9K
RSYS
3052
DELISTED
Radisys Corp
RSYS
$104K ﹤0.01%
45,200
-65,400
-59% -$174K
KBIO
3053
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$104K ﹤0.01%
2,925
APP
3054
DELISTED
AMERICAN APPAREL INC COM
APP
$102K ﹤0.01%
82,600
FBIO icon
3055
Fortress Biotech
FBIO
$89M
$101K ﹤0.01%
2,553
ACFN
3056
DELISTED
Acorn Energy Inc
ACFN
$101K ﹤0.01%
24,600
TAT
3057
DELISTED
TransAtlantic Petroleum LTD.
TAT
$99K ﹤0.01%
11,622
-4,403
-27% -$35.7K
FCSC
3058
DELISTED
Fibrocell Science Inc.
FCSC
$98K ﹤0.01%
1,600
STRP
3059
DELISTED
Straight Path Communications Inc.
STRP
$97K ﹤0.01%
11,750
INTX
3060
DELISTED
Intersections, Inc.
INTX
$96K ﹤0.01%
12,300
PTX
3061
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$94K ﹤0.01%
3,710
ENZN
3062
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$92K ﹤0.01%
79,300
-238,920
-75% -$368K
FLNA
3063
Filana Therapeutics
FLNA
$48.8M
$91K ﹤0.01%
2,657
YUME
3064
DELISTED
YuMe, Inc.
YUME
$91K ﹤0.01%
12,100
FMD
3065
DELISTED
FIRST MARBLEHEAD CORP COM STK NEW (DE)
FMD
$89K ﹤0.01%
11,990
ZAZA
3066
DELISTED
ZAZA ENERGY CORP COM NEW
ZAZA
$89K ﹤0.01%
9,260
BODY
3067
DELISTED
BODY CENTRAL CORP COM STK
BODY
$88K ﹤0.01%
22,200
HSTO
3068
DELISTED
Histogen Inc. Common Stock
HSTO
$82K ﹤0.01%
64
NETE
3069
DELISTED
NETEGRITY INC
NETE
$81K ﹤0.01%
18,500
SAUC
3070
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
$73K ﹤0.01%
15,300
GNK
3071
DELISTED
GENCO SHIPPING & TRADING LTD
GNK
$54K ﹤0.01%
21,500
CASC
3072
DELISTED
Cascadian Therapeutics, Inc.
CASC
$46K ﹤0.01%
4,283
ACUR
3073
DELISTED
Acura Pharmaceuticals
ACUR
$35K ﹤0.01%
4,180
CRRS
3074
DELISTED
CORPORATE RESOURCE SERVICES, INC. COMMON STOCK
CRRS
$32K ﹤0.01%
11,952
+1,152
+11% +$3.72K
DRRX
3075
DELISTED
DURECT Corp
DRRX
$26K ﹤0.01%
1,450

Similar funds

Charles Schwab's Q4 2013 Portfolio in Review

As of Q4 2013, Charles Schwab held 3,132 positions worth $52.5B, up 7% from $49.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q4 2013: portfolio turnover was 4.1%. Charles Schwab opened 75 new positions and exited 54, leaving the 3,132-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

  • Charles Schwab's largest Q4 2013 buy was Allergan plc: 398,955 shares worth $67M.
  • Charles Schwab added most to Meta Platforms (Facebook) in Q4 2013, an estimated $94.5M increase.
  • Charles Schwab's biggest Q4 2013 reduction was Apple, cutting an estimated $69.9M.
  • Charles Schwab fully exited DELL INC in Q4 2013, selling an estimated $45.2M.
  • Charles Schwab's ten largest holdings make up 14% of its $52.5B portfolio in Q4 2013.
  • Charles Schwab opened 75 new positions and closed 54 in Q4 2013.
  • Charles Schwab's portfolio value rose 7% quarter-over-quarter to $52.5B.

Based on Charles Schwab's 13F filing for Q4 2013, filed 14 Feb 2014.